Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlates of pain in an in-treatment sample of opioid-dependent people.
Nielsen S, Larance B, Lintzeris N, Black E, Bruno R, Murnion B, Dunlop A, Degenhardt L. Nielsen S, et al. Among authors: degenhardt l. Drug Alcohol Rev. 2013 Sep;32(5):489-94. doi: 10.1111/dar.12041. Epub 2013 Apr 17. Drug Alcohol Rev. 2013. PMID: 23594352
Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia.
Nielsen S, Bruno R, Murnion B, Dunlop A, Degenhardt L, Demirkol A, Muhleisen P, Lintzeris N. Nielsen S, et al. Among authors: degenhardt l. Drug Alcohol Rev. 2016 Jan;35(1):70-75. doi: 10.1111/dar.12315. Epub 2015 Jul 30. Drug Alcohol Rev. 2016. PMID: 26223631
[Nielsen S, Bruno R, Murnion B, Dunlop A, Degenhardt L, Demirkol A, Muhleisen P, Lintzeris N. Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia. ...
[Nielsen S, Bruno R, Murnion B, Dunlop A, Degenhardt L, Demirkol A, Muhleisen P, Lintzeris N. Treating codeine dependence with …
The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film.
White N, Ali R, Larance B, Zador D, Mattick RP, Degenhardt L. White N, et al. Among authors: degenhardt l. Drug Alcohol Rev. 2016 Jan;35(1):76-82. doi: 10.1111/dar.12317. Epub 2015 Sep 1. Drug Alcohol Rev. 2016. PMID: 26331899
[White N, Ali R, Larance B, Zador D, Mattick RP, Degenhardt L. The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film. ...
[White N, Ali R, Larance B, Zador D, Mattick RP, Degenhardt L. The extramedical use and diversion of opioid substitution medic …
Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia.
Larance B, Mattick R, Ali R, Lintzeris N, Jenkinson R, White N, Kihas I, Cassidy R, Degenhardt L. Larance B, et al. Among authors: degenhardt l. Drug Alcohol Rev. 2016 Jan;35(1):83-91. doi: 10.1111/dar.12344. Epub 2015 Oct 9. Drug Alcohol Rev. 2016. PMID: 26450513
[Larance B, Mattick R, Ali R, Lintzeris N, Jenkinson R, White N, Kihas I, Cassidy R, Degenhardt L. Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia. ...
[Larance B, Mattick R, Ali R, Lintzeris N, Jenkinson R, White N, Kihas I, Cassidy R, Degenhardt L. Diversion and injection of …
Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Nielsen S, Bruno R, Degenhardt L, Demirkol A, Lintzeris N. Nielsen S, et al. Among authors: degenhardt l. Drug Alcohol Rev. 2017 May;36(3):311-316. doi: 10.1111/dar.12418. Epub 2016 Jun 7. Drug Alcohol Rev. 2017. PMID: 27273511
Use of conversion tables to guide selection of opioid agonist dosage may compromise patient safety. [Nielsen S, Bruno R, Degenhardt L, Demirkol A, Lintzeris N. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series Drug …
Use of conversion tables to guide selection of opioid agonist dosage may compromise patient safety. [Nielsen S, Bruno R, Degenhardt …
Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence.
Nielsen S, Lintzeris N, Murnion B, Degenhardt L, Bruno R, Haber P, Johnson J, Hardy M, Ling S, Saddler C, Dunlop A, Demirkol A, Silsbury C, Phung N, Houseman J, Larance B. Nielsen S, et al. Among authors: degenhardt l. Drug Alcohol Rev. 2018 Nov;37(7):887-896. doi: 10.1111/dar.12859. Epub 2018 Oct 2. Drug Alcohol Rev. 2018. PMID: 30280448
732 results